VANCOUVER, British Columbia, Feb. 11, 2021 (GLOBE NEWSWIRE) -- Willow Biosciences Inc. ("Willow" or the "Company") (TSX: WLLW; WLLW.WT; OTCQX: CANSF) is pleased to announce that in connection with its previously announced bought deal offering, Willow and the syndicate of underwriters co-led by Eight Capital and BMO Capital Markets (collectively, the "Underwriters"), have agreed to increase the size of the bought deal offering. Willow will now issue 15,152,000 common shares of the Company (the “Common Shares”) at a price of $1.65 per Common Share (the “Offering Price”) for gross proceeds of approximately $25.0 million (the “Offering”). Read More
from Financial Post https://ift.tt/376bzyY
from Financial Post https://ift.tt/376bzyY
Comments
Post a Comment